US Patent 9738699 Recombinant fusion proteins and libraries from immune cell repertoires
Patent 9738699 was granted and assigned to Gigagen Inc on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
Disclosed herein are methods and compositions for generating a repertoire of recombinant fusion polypeptides from immune cells, and uses thereof.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Adam Adler0
David Scott Johnson0
Rena Mizrahi0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09738699 Recombinant fusion proteins and libraries from immune cell repertoires US Patent 9738699 Recombinant fusion proteins and libraries from immune cell repertoires
Infobox
Patent Number
097386990
Patent Number
97386990
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
097386990
Date of Patent
August 22, 2017
0Patent Application Number
151597050
Date Filed
May 19, 2016
0Patent Primary Examiner
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09738699 Recombinant fusion proteins and libraries from immune cell repertoires
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09738699
Date of patent
August 22, 2017
Patent application number
15159705
Date Filed
May 19, 2016
Patent primary examiner
Find more entities like US Patent 9738699 Recombinant fusion proteins and libraries from immune cell repertoires
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
